Cargando…

Human Prion Diseases in the United States

BACKGROUND: Prion diseases are a family of rare, progressive, neurodegenerative disorders that affect humans and animals. The most common form of human prion disease, Creutzfeldt-Jakob disease (CJD), occurs worldwide. Variant CJD (vCJD), a recently emerged human prion disease, is a zoonotic foodborn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holman, Robert C., Belay, Ermias D., Christensen, Krista Y., Maddox, Ryan A., Minino, Arialdi M., Folkema, Arianne M., Haberling, Dana L., Hammett, Teresa A., Kochanek, Kenneth D., Sejvar, James J., Schonberger, Lawrence B.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797136/ https://www.ncbi.nlm.nih.gov/pubmed/20049325 http://dx.doi.org/10.1371/journal.pone.0008521

Ejemplares similares

QuickStats
por: Minino, Arialdi
Publicado: (2013)

Prions and Prion Diseases: Current Perspectives
por: Belay, Ermias D.
Publicado: (2004)

Human Prion Disease Surveillance in Washington State, 2006-2017
por: Sánchez-González, Liliana, et al.
Publicado: (2020)

Prions: The New Biology of Proteins
por: Belay, Ermias D.
Publicado: (2007)

Chronic Wasting Disease and Potential Transmission to Humans
por: Belay, Ermias D., et al.
Publicado: (2004)

Variant Creutzfeldt-Jakob Disease Death, United States
por: Belay, Ermias D., et al.
Publicado: (2005)

Etymologia: Prion
por: Schonberger, Lawrence B., et al.
Publicado: (2012)

Provisional Mortality Data — United States, 2020
por: Ahmad, Farida B., et al.
Publicado: (2021)

Prions: Current Progress in Advanced Research
por: Maddox, Ryan A.
Publicado: (2014)

Multiorgan Detection and Characterization of Protease-Resistant Prion Protein in a Case of Variant CJD Examined in the United States
por: Notari, Silvio, et al.
Publicado: (2010)

Corticosteroids Added to Initial Intravenous Immunoglobulin Treatment for the Prevention of Coronary Artery Abnormalities in High‐Risk Patients With Kawasaki Disease
por: Ae, Ryusuke, et al.
Publicado: (2020)

Kawasaki Disease With Coronary Artery Lesions Detected at Initial Echocardiography
por: Ae, Ryusuke, et al.
Publicado: (2021)

Creutzfeldt-Jakob disease in the United States, 1979-1994: using national mortality data to assess the possible occurrence of variant cases.
por: Holman, R C, et al.
Publicado: (1996)

Evaluation of seasonal patterns of Kawasaki Syndrome- and rotavirus-associated hospitalizations in California and New York, 2000-2005
por: MacNeil, Adam, et al.
Publicado: (2009)

Recent US Case of Variant Creutzfeldt-Jakob Disease—Global Implications
por: Maheshwari, Atul, et al.
Publicado: (2015)

Update: Dura Mater Graft–Associated Creutzfeldt-Jakob Disease — Japan, 1975–2017
por: Ae, Ryusuke, et al.
Publicado: (2018)

Distinct pathological phenotypes of Creutzfeldt-Jakob disease in recipients of prion-contaminated growth hormone
por: Cali, Ignazio, et al.
Publicado: (2015)

Barriers to Creutzfeldt-Jakob Disease Autopsies, California
por: Louie, Janice K., et al.
Publicado: (2004)

Molluscum Contagiosum in a Pediatric American Indian Population: Incidence and Risk Factors
por: McCollum, Andrea M., et al.
Publicado: (2014)

Co-occurrence of chronic traumatic encephalopathy and prion disease
por: Nemani, Satish Kumar, et al.
Publicado: (2018)

Sporadic fatal insomnia in a young woman: A diagnostic challenge: Case Report
por: Moody, Karen M, et al.
Publicado: (2011)

Zika Virus infection and Guillain-Barré syndrome in Northeastern Mexico: A case-control study
por: Gongora-Rivera, Fernando, et al.
Publicado: (2020)

Prion protein lacks robust cytoprotective activity in cultured cells
por: Christensen, Heather M, et al.
Publicado: (2008)

PrionHome: A Database of Prions and Other Sequences Relevant to Prion Phenomena
por: Harbi, Djamel, et al.
Publicado: (2012)

Accelerated High Fidelity Prion Amplification Within and Across Prion Species Barriers
por: Green, Kristi M., et al.
Publicado: (2008)

Clay Components in Soil Dictate Environmental Stability and Bioavailability of Cervid Prions in Mice
por: Wyckoff, A. Christy, et al.
Publicado: (2016)

Increasing trend in the rate of infectious disease hospitalisations among Alaska Native people
por: Holman, Robert C., et al.
Publicado: (2013)

Epidemiology of Kawasaki Disease in Asia, Europe, and the United States
por: Uehara, Ritei, et al.
Publicado: (2012)

Low-Incidence, High-Consequence Pathogens
por: Belay, Ermias D., et al.
Publicado: (2014)

Increasing Prion Propensity by Hydrophobic Insertion
por: Gonzalez Nelson, Aaron C., et al.
Publicado: (2014)

Classifying prion and prion-like phenomena
por: Harbi, Djamel, et al.
Publicado: (2014)

Treatment of Prion Disease with Heterologous Prion Proteins
por: Skinner, Pamela J., et al.
Publicado: (2015)

Long-term outcomes of Guillain-Barré syndrome possibly associated with Zika virus infection
por: Walteros, Diana M., et al.
Publicado: (2019)

Prion propagation estimated from brain diffusion MRI is subtype dependent in sporadic Creutzfeldt–Jakob disease
por: Pascuzzo, Riccardo, et al.
Publicado: (2020)

SARS-CoV-2 spread and hospitalisations in paediatric patients during the omicron surge
por: Belay, Ermias D, et al.
Publicado: (2022)

Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study
por: Abrams, Joseph Y, et al.
Publicado: (2021)

Potential approaches for heterologous prion protein treatment of prion diseases
por: Seelig, Davis M., et al.
Publicado: (2015)

Differential Accumulation of Misfolded Prion Strains in Natural Hosts of Prion Diseases
por: Lambert, Zoe J., et al.
Publicado: (2021)

Prion Amplification and Hierarchical Bayesian Modeling Refine Detection of Prion Infection
por: Wyckoff, A. Christy, et al.
Publicado: (2015)

Conservation of Prion-Like Composition and Sequence in Prion-Formers and Prion-Like Proteins of Saccharomyces cerevisiae
por: Su, Ting-Yi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b1o5e559f1fjvbo1v50tq4i1kl